Literature DB >> 27246566

Omega-3 Fatty Acids and Mood Stabilizers Alter Behavioural and Energy Metabolism Parameters in Animals Subjected to an Animal Model of Mania Induced by Fenproporex.

Kizzy Cancelier1, Lara M Gomes1, Milena Carvalho-Silva1, Letícia J Teixeira1, Joyce Rebelo1, Isabella T Mota1, Camila O Arent2, Edemilson Mariot2, Luiza W Kist3, Maurício R Bogo3, João Quevedo4,5,2, Giselli Scaini6,7, Emilio L Streck1.   

Abstract

Studies have shown that changes in energy metabolism are involved in the pathophysiology of bipolar disorder (BD). It was suggested that omega-3 (ω3) fatty acids have beneficial properties in the central nervous system and that this fatty acid plays an important role in energy metabolism. Therefore, the study aimed to evaluate the effect of ω3 fatty acids alone and in combination with lithium (Li) or valproate (VPA) on behaviour and parameters of energy metabolism in an animal model of mania induced by fenproporex. Our results showed that co-administration of ω3 fatty acids and Li was able to prevent and reverse the increase in locomotor and exploratory activity induced by fenproporex. The combination of ω3 fatty acids with VPA was only able to prevent the fenproporex-induced hyperactivity. For the energy metabolism parameters, our results showed that the administration of Fen for the reversal or prevention protocol inhibited the activities of succinate dehydrogenase, complex II and complex IV in the hippocampus. However, hippocampal creatine kinase (CK) activity was decreased only for the reversal protocol. The ω3 fatty acids, alone and in combination with VPA or Li, prevented and reversed the decrease in complex II, IV and succinate dehydrogenase activity, whereas the decrease in CK activity was only reversed after the co-administration of ω3 fatty acids and VPA. In conclusion, our results showed that the ω3 fatty acids combined with VPA or Li were able to prevent and reverse manic-like hyperactivity and the inhibition of energy metabolism in the hippocampus, suggesting that ω3 fatty acids may play an important role in the modulation of behavioural parameters and energy metabolism.

Entities:  

Keywords:  Bipolar disorder; Fenproporex; Lithium; Omega-3 fatty acids; Valproate energy metabolism

Mesh:

Substances:

Year:  2016        PMID: 27246566     DOI: 10.1007/s12035-016-9933-z

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  77 in total

1.  A method for the estimation of serum creatine kinase and its use in comparing creatine kinase and aldolase activity in normal and pathological sera.

Authors:  B P HUGHES
Journal:  Clin Chim Acta       Date:  1962-09       Impact factor: 3.786

Review 2.  Omega-3 fatty acids and antioxidants in neurological and psychiatric diseases: an overview.

Authors:  Marianna Mazza; Massimiliano Pomponi; Luigi Janiri; Pietro Bria; Salvatore Mazza
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2006-08-28       Impact factor: 5.067

3.  Photocell measurements of rat motor activity. A contribution to sensitivity and variation in behavioral observations.

Authors:  E Ericson; J Samuelsson; S Ahlenius
Journal:  J Pharmacol Methods       Date:  1991-04

Review 4.  Receptor targets for antidepressant therapy in bipolar disorder: an overview.

Authors:  Konstantinos N Fountoulakis; John R Kelsoe; Hagop Akiskal
Journal:  J Affect Disord       Date:  2011-05-20       Impact factor: 4.839

5.  Effects of lithium and valproate on amphetamine-induced oxidative stress generation in an animal model of mania.

Authors:  Benicio N Frey; Samira S Valvassori; Gislaine Z Réus; Márcio R Martins; Fabrícia C Petronilho; Katrine Bardini; Felipe Dal-Pizzol; Flávio Kapczinski; João Quevedo
Journal:  J Psychiatry Neurosci       Date:  2006-09       Impact factor: 6.186

Review 6.  Dietary polyunsaturated fatty acids and depression: when cholesterol does not satisfy.

Authors:  J R Hibbeln; N Salem
Journal:  Am J Clin Nutr       Date:  1995-07       Impact factor: 7.045

7.  Differential inhibitory action of nitric oxide and peroxynitrite on mitochondrial electron transport.

Authors:  A Cassina; R Radi
Journal:  Arch Biochem Biophys       Date:  1996-04-15       Impact factor: 4.013

8.  Dietary omega-3 polyunsaturated fatty acids inhibit phosphoinositide formation and chemotaxis in neutrophils.

Authors:  R I Sperling; A I Benincaso; C T Knoell; J K Larkin; K F Austen; D R Robinson
Journal:  J Clin Invest       Date:  1993-02       Impact factor: 14.808

Review 9.  Roles of unsaturated fatty acids (especially omega-3 fatty acids) in the brain at various ages and during ageing.

Authors:  J M Bourre
Journal:  J Nutr Health Aging       Date:  2004       Impact factor: 4.075

10.  Explicit and implicit facial affect recognition in manic and depressed States of bipolar disorder: a functional magnetic resonance imaging study.

Authors:  Chi-Hua Chen; Belinda Lennox; Rebecca Jacob; Andrew Calder; Vicky Lupson; Ruth Bisbrown-Chippendale; John Suckling; Ed Bullmore
Journal:  Biol Psychiatry       Date:  2005-08-22       Impact factor: 13.382

View more
  4 in total

1.  Brain cytochrome-c-oxidase as a marker of mitochondrial function: A pilot study in major depression using NIRS.

Authors:  Lisa Holper; Martin J Lan; Patrick J Brown; Elizabeth M Sublette; Ainsley Burke; John J Mann
Journal:  Depress Anxiety       Date:  2019-05-21       Impact factor: 6.505

2.  Omega-3 fatty acid supplementation can prevent changes in mitochondrial energy metabolism and oxidative stress caused by chronic administration of L-tyrosine in the brain of rats.

Authors:  Milena Carvalho-Silva; Lara M Gomes; Maria L Gomes; Bruna K Ferreira; Patricia F Schuck; Gustavo C Ferreira; Felipe Dal-Pizzol; Jade de Oliveira; Giselli Scaini; Emilio L Streck
Journal:  Metab Brain Dis       Date:  2019-04-04       Impact factor: 3.584

3.  Omega-3 fatty acids and mood stabilizers alter behavioral and oxidative stress parameters in animals subjected to fenproporex administration.

Authors:  Lara M Gomes; Milena Carvalho-Silva; Letícia J Teixeira; Joyce Rebelo; Isabella T Mota; Rafaela Bilesimo; Monique Michels; Camila O Arent; Edemilson Mariot; Felipe Dal-Pizzol; Giselli Scaini; João Quevedo; Emilio L Streck
Journal:  Metab Brain Dis       Date:  2016-12-16       Impact factor: 3.584

Review 4.  Therapeutic approaches employing natural compounds and derivatives for treating bipolar disorder: emphasis on experimental models of the manic phase.

Authors:  Vânia Machado Recart; Luiza Spohr; Mayara Sandrielly Pereira Soares; Karina Pereira Luduvico; Francieli Moro Stefanello; Roselia Maria Spanevello
Journal:  Metab Brain Dis       Date:  2021-07-15       Impact factor: 3.584

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.